Researchers at Oregon Health & Science University are challenging the convention that tetanus and diphtheria vaccine boosters need to be administered every 10 years. Their paper in Clinical Infectious Diseases recommends that the current adult ...

State-of-the-art cancer research facility will support a collaborative atmosphere, bring multidisciplinary scientists together under one roof.

OHSU expert co-authors viewpoint: ‘Time’s up for medicine? Only time will tell.’

The hybrid cells, readily detected in cancer patients’ blood, gain new powers to mobilize and form new tumors.

'It's clear to me that OHSU is a special place," says OHSU's President-select, Dr. Danny Jacobs.

One of the most highly cited medical scientists in the world, Mills brings a breadth of research, leadership experience to OHSU.

A machine-learning algorithm can predict long-term brain impact, and may identify early treatment opportunities for children.

Findings have significant implications for opioid conversations between patients and their providers.

NIH-funded trial offers hope for disease with limited treatment options.

OHSU included in an expanded clinical trial assessing the effectiveness of immunotherapy to treat or slow Parkinson's disease.